Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Francine Foss, MD
Yale University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
68 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Dch Cancer Treatment Center
Tuscaloosa, Alabama, United States
- Arizona Cancer Center
Tucson, Arizona, United States
- Genesis Cancer Center
Hot Springs, Arkansas, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- City of Hope National Medical Center
Duarte, California, United States
- Moores Cancer Center Ucsd
La Jolla, California, United States
- Wilshire Oncology Medical Group
La Verne, California, United States
- Ucla
Los Angeles, California, United States
- Usc & Norris Cancer Center
Los Angeles, California, United States
- Stanford University Medical Center
Stanford, California, United States
- Ucla Olive View Medical Center
Sylmar, California, United States
- Danbury Hospital Praxair Cancer Center
Danbury, Connecticut, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- Georgetown University
Washington D.C., District of Columbia, United States
- Washington Cancer Institute at Washington Hospital Center
Washington D.C., District of Columbia, United States
- Coral Springs Oncology
Coral Springs, Florida, United States
- Medical Specialists of the Palm Beaches
Lake Worth, Florida, United States
- Hematology Oncology Associates
Loxahatchee Groves, Florida, United States
- University of Miami
Miami, Florida, United States
- Md Anderson Orlando
Orlando, Florida, United States
- Moffit Cancer Center
Tampa, Florida, United States
- Emory University Cancer Center
Atlanta, Georgia, United States
- Georgia Cancer Specialists
Atlanta, Georgia, United States
- Medical College of Georgia
Augusta, Georgia, United States
- Kootenai Cancer Center
Post Falls, Idaho, United States
- John H. Stroger, Jr. Hospital of Cook County
Chicago, Illinois, United States
- Northwestern University
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Uic Cancer Center
Chicago, Illinois, United States
- University of Chicago Medical Center
Chicago, Illinois, United States
- Simmons Cooper Cancer Institute at Siu School of Medicine
Springfield, Illinois, United States
- Indiana University Simon Cancer Center
Indianapolis, Indiana, United States
- St. Francis Medical Group Oncology and Hematology Associates
Indianapolis, Indiana, United States
- Louisiana State University Health Science Center (lsuhsc)
Shreveport, Louisiana, United States
- University of Maryland
Baltimore, Maryland, United States
- Boston Medical Center
Boston, Massachusetts, United States
- Michigan State University
East Lansing, Michigan, United States
- Genesys Hurley Cancer Institute
Flint, Michigan, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
- Promedica
Lambertville, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2010
- Primary completion
- 31 Dec 2019
- Completion
- 31 Dec 2019
- Last update posted
- 13 Jan 2020
- Registered enrollment
- 3,000
- Registry id
- NCT01110733
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.